Azelis Group NV (AZE) | Financial Analysis & Statements
Azelis Group NV Large-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
5.4B
Total Liabilities
2.7B
Shareholders Equity
2.7B
Debt to Equity
0.99
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2025
Azelis Group NV Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 4.1B | 4.2B | 4.2B | 4.1B | 2.8B |
| Cost of Goods Sold | 3.2B | 3.2B | 3.2B | 3.2B | 2.2B |
| Gross Profit | 968.5M | 1.0B | 984.1M | 960.7M | 650.1M |
| Gross Margin % | 23.4% | 24.3% | 23.6% | 23.3% | 22.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 172.5M | 175.0M | 166.8M | 158.8M | 117.3M |
| Other Operating Expenses | 32.4M | 38.8M | 25.1M | 41.9M | 30.6M |
| Total Operating Expenses | 204.9M | 213.8M | 191.9M | 200.7M | 147.9M |
| Operating Income | 313.3M | 385.9M | 386.9M | 388.4M | 207.8M |
| Operating Margin % | 7.6% | 9.1% | 9.3% | 9.4% | 7.3% |
| Non-Operating Items | |||||
| Interest Income | 5.1M | 14.8M | 10.7M | 621.0K | 618.0K |
| Interest Expense | 95.8M | 106.0M | 97.4M | 38.2M | 49.9M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 175.2M | 256.1M | 247.2M | 314.7M | 120.2M |
| Income Tax | 61.8M | 66.6M | 57.9M | 95.8M | 50.0M |
| Effective Tax Rate % | 35.3% | 26.0% | 23.4% | 30.4% | 41.6% |
| Net Income | 113.4M | 189.5M | 189.3M | 218.9M | 70.2M |
| Net Margin % | 2.7% | 4.5% | 4.5% | 5.3% | 2.5% |
| Key Metrics | |||||
| EBITDA | 397.8M | 471.3M | 466.9M | 457.8M | 229.5M |
| EPS (Basic) | €0.46 | €0.74 | €0.74 | €0.91 | €0.29 |
| EPS (Diluted) | €0.46 | €0.74 | €0.74 | €0.91 | €0.29 |
| Basic Shares Outstanding | 243512000 | 244179730 | 240140541 | 233750000 | 233846000 |
| Diluted Shares Outstanding | 243512000 | 244179730 | 240140541 | 233750000 | 233846000 |
Income Statement Trend
Azelis Group NV Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 263.0M | 303.9M | 484.9M | 268.2M | 141.3M |
| Short-term Investments | 5.0K | 604.0K | 60.0K | 280.0K | 1.5M |
| Accounts Receivable | 439.8M | 496.4M | 444.9M | 443.3M | 429.0M |
| Inventory | 588.2M | 677.9M | 562.8M | 627.7M | 467.5M |
| Other Current Assets | - | -1.0K | -1.0K | -1.0K | - |
| Total Current Assets | 1.4B | 1.6B | 1.6B | 1.4B | 1.0B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 115.2M | 103.9M | 88.1M | 58.0M | 118.6M |
| Goodwill | 6.2B | 6.5B | 6.2B | 5.5B | 4.6B |
| Intangible Assets | 1.3B | 1.4B | 1.3B | 1.2B | 1.0B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.0K | -1.0K | -3.0K | -2.0K | - |
| Total Non-Current Assets | 4.0B | 4.2B | 4.0B | 3.5B | 2.9B |
| Total Assets | 5.4B | 5.8B | 5.6B | 5.0B | 4.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 438.4M | 486.8M | 434.1M | 462.7M | 368.7M |
| Short-term Debt | 137.2M | 95.6M | 125.1M | 176.1M | 118.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | -1.0K | - | - | - | - |
| Total Current Liabilities | 709.8M | 818.9M | 939.8M | 975.3M | 678.4M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.7B | 1.7B | 1.7B | 1.3B | 894.1M |
| Deferred Tax Liabilities | 220.8M | 225.9M | 218.3M | 190.8M | 135.3M |
| Other Non-Current Liabilities | - | - | - | - | 9.7M |
| Total Non-Current Liabilities | 2.0B | 2.0B | 2.0B | 1.6B | 1.1B |
| Total Liabilities | 2.7B | 2.8B | 2.9B | 2.5B | 1.7B |
| Equity | |||||
| Common Stock | 5.9B | 5.9B | 5.9B | 5.7B | 5.7B |
| Retained Earnings | 989.8M | 876.3M | 637.1M | 405.8M | 164.6M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.7B | 2.9B | 2.7B | 2.4B | 2.3B |
| Key Metrics | |||||
| Total Debt | 1.9B | 1.8B | 1.8B | 1.4B | 1.0B |
| Working Capital | 676.8M | 764.0M | 653.7M | 469.2M | 365.2M |
Balance Sheet Composition
Azelis Group NV Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 113.4M | 189.5M | 189.3M | 218.9M | 70.2M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 1.8M | 1.3M | 1.4M | 839.0K | 0 |
| Working Capital Changes | 97.0M | -153.3M | 203.0M | -38.6M | -149.3M |
| Operating Cash Flow | 336.7M | 183.0M | 525.6M | 255.0M | 16.9M |
| Investing Activities | |||||
| Capital Expenditures | -24.9M | -13.9M | -15.5M | -18.4M | -18.3M |
| Acquisitions | -151.9M | -241.5M | -584.6M | -553.7M | -633.9M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -176.8M | -255.3M | -600.1M | -572.1M | -652.2M |
| Financing Activities | |||||
| Share Repurchases | -1.1M | -2.5M | -3.4M | -3.0M | 0 |
| Dividends Paid | -54.9M | -53.3M | -67.8M | -7.0M | - |
| Debt Issuance | 278.1M | 1.3B | 768.1M | 640.6M | 909.7M |
| Debt Repayment | -256.1M | -1.2B | -453.4M | -217.4M | -1.2B |
| Financing Cash Flow | -110.6M | -73.5M | 443.3M | 407.2M | 608.3M |
| Free Cash Flow | 396.8M | 309.1M | 509.6M | 350.8M | 143.6M |
| Net Change in Cash | 49.3M | -145.8M | 368.9M | 90.1M | -27.0M |
Cash Flow Trend
Azelis Group NV Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
22.61
Forward P/E
12.25
Price to Book
0.94
Price to Sales
0.62
PEG Ratio
12.25
Profitability Ratios
Profit Margin
2.71%
Operating Margin
6.87%
Return on Equity
4.03%
Return on Assets
3.65%
Financial Health
Current Ratio
1.95
Debt to Equity
69.00
Beta
0.37
Per Share Data
EPS (TTM)
€0.46
Book Value per Share
€11.07
Revenue per Share
€16.88
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| AZE | 2.5B | 22.61 | 0.94 | 4.03% | 2.71% | 69.00 |
| Syneos Health | 5.7B | 377.86 | 0.94 | -1.25% | -1.04% | 48.61 |
| Titan Cement | 3.5B | 14.74 | 1.77 | 13.18% | 8.85% | 33.45 |
| Solvay SA | 2.9B | 99.64 | 2.86 | 2.98% | 0.63% | 200.56 |
| Tessenderlo Group NV | 1.3B | 37.21 | 0.74 | -4.43% | -2.94% | 11.70 |
Financial data is updated regularly. All figures are in the company's reporting currency.